Back

Hypertensive heart disease and hypertrophic cardiomyopathy share a similar degree of cardiac energetic impairment

30 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Heart in hypertension Target Organ Damage/Left Ventricular Hypertrophy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Niklas Beyhoff

German Heart Centre Berlin, Berlin (Germany)

5 More presentations in this session

Presentation thumbnail
Left ventricular hypertrophy in the automatic electrocardiogram report and mortality risk
Doctor G. Paixao (Belo Horizonte, BR)
Abstract Slides Video
Presentation thumbnail
Association of subclinical cardiac changes, systolic blood pressure, and cardiovascular outcomes
Doctor A. Cai (Guangzhou, CN)
Abstract Slides Video
Presentation thumbnail
Home blood pressure control status altered the cardiovascular prognosis associated with left ventricular hypertrophy in a Japanese nationwide general practice population: The J-HOP Study
Doctor T. Fujiwara (Shimotsuke, JP)
Abstract Slides Video
Presentation thumbnail
Hypertension and mortality risk in heart failure: a gender-specific analysis of HF subtypes
Doctor V. Copeland (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation recurrence prediction after radiofrequency ablation for patients with atrial fibrillation and hypertension using the systemic immune inflammation and left ventricular mass indices
Doctor L. Wang (Lanzhou, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Heart in hypertension

The Event

Event poster

ESC Congress 2025

30 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Impaired myocardial energetics in both sarcomere positive and negative HCM are linked to arrhythmic risk
thumbnail
Congress Session
Advancing care in hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Multiparametric CMR detects a higher burden of microstructural and metabolic abnormalities in sarcomeric HCM compared to non-sarcomeric HCM

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources